Aspirin and Cancer

By Rachel Airley, EPB Board member and Senior Lecturer in Pharmacology

There is now wealth of evidence from clinical trials that aspirin can not only prevent cancer, but can also slow the growth and spread of bowel cancers already present.  While the evidence is there, doctors and pharmacists have been somewhat reticent when it comes to recommending the wholesale use of aspirin in patients at risk, or already undergoing treatment for bowel cancer, due to fears that this will lead to side effects such as gastric ulcer or bleeding.

Read more Aspirin and Cancer